Baxter (BAX) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Leerink Partners Downgrades Baxter International (BAX) to Market Perform
July 30, 2015 7:43 AM EDTLeerink Partners downgraded Baxter International (NYSE: BAX) from Outperform to Market Perform with a price target of $40.00 (from $82.00).
Analyst Danielle Antalffy commented, "We are downgrading BAX shares to MP with a $40 12-month price target. Despite delivering solid 2Q15 results, post-split new BAX valuation appears lofty to us, already seeming to factor in potential upside in both sales... More
Baxter (BAX) Declares $0.115 Quarterly Dividend; 1.2% Yield
July 29, 2015 4:18 PM EDTBaxter (NYSE: BAX) declared a quarterly dividend at a new rate of $0.115 per share, or $0.46 annualized, following its successful spin-off of its biopharmaceuticals business, Baxalta Incorporated.
The dividend will be payable on October 1, 2015, to stockholders of record on September 4, 2015, with an ex-dividend... More
